BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13859504)

  • 1. Progressive muscular dystrophy. II. Biochemical identification of the carrier state in the recessive sex-linked juvennile (Duchenne) type by serum creatine-phosphokinase determinations.
    AEBI U; RICHTERICH R; COLOMBO JP; ROSSI E
    Epilepsia; 1961-1962; 1():61-74. PubMed ID: 13859504
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases.
    OKINAKA S; KUMAGAI H; EBASHI S; SUGITA H; MOMOI H; TOYOKURA Y; FUJIE Y
    Arch Neurol; 1961 May; 4():520-5. PubMed ID: 13730599
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. II. Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity.
    Gale AN; Murphy EA
    J Chronic Dis; 1979; 32(9-10):639-51. PubMed ID: 489704
    [No Abstract]   [Full Text] [Related]  

  • 4. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women.
    Smith I; Elton RA; Thomson WH
    Clin Chim Acta; 1979 Nov; 98(3):207-16. PubMed ID: 498534
    [No Abstract]   [Full Text] [Related]  

  • 5. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 6. An aberrant adenylate kinase isoenzyme from the serum of patients with Duchenne muscular dystrophy.
    Hamada M; Okuda H; Oka K; Watanabe T; Ueda K; Nojima M; Kuby SA; Manship M; Tyler FH; Ziter FA
    Biochim Biophys Acta; 1981 Aug; 660(2):227-37. PubMed ID: 6269633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carrier state in muscular dystrophy of the Duchenne type.
    Milhorat AT; Goldstone L
    JAMA; 1965 Oct; 194(2):130-4. PubMed ID: 5897511
    [No Abstract]   [Full Text] [Related]  

  • 8. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 9. An investigation of the carrier state in the Duchenne type muscular dystrophy.
    LEYBURN P; THOMSON WH; WALTON JN
    Ann Hum Genet; 1961 May; 25():41-9. PubMed ID: 13761775
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of carrier states in progressive muscular dystrophy of the Duchenne X-recessive type. Correlative pluridimensional investigations].
    Radu H; Roşu AM; Killyen I; Ionescu V
    Pediatria (Bucur); 1973; 22(2):97-110. PubMed ID: 4720589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic counseling in progressive muscular dystrophy].
    Hemke G; Szibor R; Braun H
    Beitr Orthop Traumatol; 1975 Jan; 22(1):28-9. PubMed ID: 1122231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERUM ENZYME STUDIES IN MUSCLE DISEASE. III. SERUM CREATINE KINASE ACTIVITY IN RELATIVES OF PATIENTS WITH THE DUCHENNE TYPE OF MUSCULAR DYSTROPHY.
    PEARCE JM; PENNINGTON RJ; WALTON JN
    J Neurol Neurosurg Psychiatry; 1964 Jun; 27(3):181-5. PubMed ID: 14175282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ceruloplasmin in patients with Duchenne muscular dystrophy].
    Reyes J; Holmgren J; Colombo M
    Rev Med Chil; 1991 Mar; 119(3):258-61. PubMed ID: 1842117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERUM ENZYME VARIATIONS AND HISTOLOGICAL ABNORMALITIES IN THE CARRIER STATE IN DUCHENNE DYSTROPHY.
    STEPHENS J; LEWIN E
    J Neurol Neurosurg Psychiatry; 1965 Apr; 28(2):104-8. PubMed ID: 14285647
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet diphenoloxidases in progressive muscular dystrophy (P.M.D.).
    Dèmos J
    Clin Genet; 1973; 4(2):79-90. PubMed ID: 4199873
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum enzymes in carriers of muscular dystrophy.
    HUGHES BP
    Br Med J; 1962 Oct; 2(5310):963-4. PubMed ID: 14449788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.